The Moroccan Rare Diseases Alliance (AMRM) organized its 7th associative forum on rare diseases in Casablanca on November 15, 2026. The event's theme was "Clinical Trials and Rare Diseases." Rare diseases affect less than 1 in 2,000 people, with approximately 8,000 such conditions existing. In Morocco, around 1.5 million people, or 5% of the population, are impacted by these diseases. Despite progress in managing them, only 5% of rare diseases have specific medicinal treatments.
The development of new medications involves a lengthy process of clinical trials in multiple phases to assess efficacy and safety in humans. The first phase tests the drug on a small number of people, while the second phase involves more patients to establish its effect and safety. The third phase compares the drug to existing treatments or a placebo. After authorization, the drug is continuously monitored in its everyday use, known as phase 4. For rare diseases, conducting clinical trials presents additional challenges due to difficulties in identifying and recruiting patients.
The success of clinical trials for rare diseases relies on close coordination among healthcare industries, investigative centers, regulatory authorities, and patient associations. This requires a structured hospital network, recognized expert centers, and a stringent regulatory framework. Morocco has a legislative and institutional framework governing clinical trials, which is currently being structured. However, there is a lack of information on the nature of clinical trials conducted in the country.
The 7th Forum on Rare Diseases aimed to address this gap by providing an accurate overview of clinical trials in Morocco. The event also highlighted the role of artificial intelligence, the pharmaceutical industry, and patient associations in promoting clinical trials. The forum is an annual gathering for patient associations and individuals affected by rare diseases, fostering connections and sharing experiences.
According to the Moroccan Rare Diseases Alliance, the forum's primary mission is to unite associations and establish a tradition of exchanging lived experiences through the discussion of fundamental themes. The event provided a platform for stakeholders to discuss challenges and opportunities in the field of rare diseases.
The Moroccan healthcare system faces specific challenges in managing rare diseases due to their rarity and the resulting complexities in diagnosis and treatment. The country's pharmaceutical industry and regulatory framework play critical roles in facilitating access to treatments and promoting research.
The 7th Forum on Rare Diseases concluded with a renewed emphasis on collaboration and innovation in addressing the challenges of rare diseases in Morocco. By bringing together stakeholders and promoting dialogue, the event contributed to efforts aimed at improving the lives of individuals affected by these conditions.
Key points
- The forum highlighted the need for better coordination and information sharing among stakeholders to advance clinical trials for rare diseases in Morocco.
Reporting sources
- 7e Forum associatif des maladies rares, focus sur les essais cliniques · La Nouvelle Tribune